Leisure Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $266K | Hold |
9,483
| – | – | 0.09% | 126 |
|
|
2025
Q4 | $236K | Hold |
9,483
| – | – | 0.08% | 130 |
|
|
2025
Q3 | $242K | Sell |
9,483
-2,167
| -19% | -$53.5K | 0.08% | 124 |
|
|
2025
Q2 | $282K | Buy |
11,650
+1,211
| +12% | +$28.2K | 0.11% | 116 |
|
|
2025
Q1 | $265K | Hold |
10,439
| – | – | 0.11% | 122 |
|
|
2024
Q4 | $277K | Sell |
10,439
-670
| -6% | -$18.2K | 0.11% | 123 |
|
|
2024
Q3 | $321K | Sell |
11,109
-293
| -3% | -$8.55K | 0.14% | 117 |
|
|
2024
Q2 | $319K | Sell |
11,402
-1,466
| -11% | -$40.4K | 0.15% | 118 |
|
|
2024
Q1 | $357K | Buy |
12,868
+880
| +7% | +$24.4K | 0.18% | 109 |
|
|
2023
Q4 | $345K | Sell |
11,988
-556
| -4% | -$16.8K | 0.19% | 108 |
|
|
2023
Q3 | $416K | Sell |
12,544
-1,422
| -10% | -$50.3K | 0.24% | 97 |
|
|
2023
Q2 | $512K | Sell |
13,966
-2,210
| -14% | -$86K | 0.28% | 93 |
|
|
2023
Q1 | $660K | Sell |
16,176
-2,824
| -15% | -$122K | 0.38% | 85 |
|
|
2022
Q4 | $974K | Sell |
19,000
-100
| -0.5% | -$4.79K | 0.5% | 65 |
|
|
2022
Q3 | $836K | Buy |
19,100
+5,006
| +36% | +$243K | 0.51% | 68 |
|
|
2022
Q2 | $739K | Hold |
14,094
| – | – | 0.38% | 79 |
|
|
2022
Q1 | $730K | Hold |
14,094
| – | – | 0.37% | 87 |
|
|
2021
Q4 | $832K | Sell |
14,094
-556
| -4% | -$27.5K | 0.38% | 84 |
|
|
2021
Q3 | $630K | Sell |
14,650
-80
| -0.5% | -$3.54K | 0.34% | 92 |
|
|
2021
Q2 | $577K | Sell |
14,730
-108
| -0.7% | -$4.2K | 0.32% | 92 |
|
|
2021
Q1 | $538K | Buy |
14,838
+179
| +1% | +$6.36K | 0.33% | 95 |
|
|
2020
Q4 | $540K | Sell |
14,659
-792
| -5% | -$29.1K | 0.35% | 90 |
|
|
2020
Q3 | $538K | Sell |
15,451
-2,037
| -12% | -$71.4K | 0.4% | 81 |
|
|
2020
Q2 | $543K | Sell |
17,488
-848
| -5% | -$28.8K | 0.44% | 78 |
|
|
2020
Q1 | $568K | Sell |
18,336
-2,405
| -12% | -$81.9K | 0.55% | 63 |
|
|
2019
Q4 | $771K | Sell |
20,741
-845
| -4% | -$30.1K | 0.62% | 60 |
|
|
2019
Q3 | $736K | Sell |
21,586
-1,668
| -7% | -$60.7K | 0.62% | 59 |
|
|
2019
Q2 | $956K | Sell |
23,254
-3,342
| -13% | -$133K | 0.84% | 35 |
|
|
2019
Q1 | $1.07M | Sell |
26,596
-2,634
| -9% | -$105K | 0.9% | 28 |
|
|
2018
Q4 | $1.21M | Sell |
29,230
-1,154
| -4% | -$47.9K | 1.14% | 22 |
|
|
2018
Q3 | $1.27M | Sell |
30,384
-845
| -3% | -$32.5K | 1.03% | 25 |
|
|
2018
Q2 | $1.07M | Sell |
31,229
-14,482
| -32% | -$495K | 0.92% | 27 |
|
|
2018
Q1 | $1.54M | Sell |
45,711
-10,878
| -19% | -$374K | 1.35% | 25 |
|
|
2017
Q4 | $1.95M | Buy |
56,589
+1,976
| +4% | +$67.4K | 1.62% | 20 |
|
|
2017
Q3 | $1.85M | Sell |
54,613
-64
| -0.1% | -$2.06K | 1.62% | 22 |
|
|
2017
Q2 | $1.74M | Sell |
54,677
-1,268
| -2% | -$40K | 1.55% | 29 |
|
|
2017
Q1 | $1.82M | Sell |
55,945
-4,610
| -8% | -$145K | 1.61% | 27 |
|
|
2016
Q4 | $1.87M | Sell |
60,555
-503
| -0.8% | -$15.4K | 1.68% | 25 |
|
|
2016
Q3 | $1.96M | Sell |
61,058
-472
| -0.8% | -$15.8K | 1.84% | 20 |
|
|
2016
Q2 | $2.06M | Sell |
61,530
-661
| -1% | -$21.1K | 2.02% | 18 |
|
|
2016
Q1 | $1.75M | Sell |
62,191
-460
| -0.7% | -$13.1K | 1.74% | 24 |
|
|
2015
Q4 | $1.92M | Buy |
62,651
+927
| +2% | +$29.2K | 1.75% | 22 |
|
|
2015
Q3 | $1.84M | Sell |
61,724
-455
| -0.7% | -$14.6K | 2% | 15 |
|
|
2015
Q2 | $1.98M | Buy |
62,179
+818
| +1% | +$26.7K | 1.95% | 13 |
|
|
2015
Q1 | $2.02M | Buy |
61,361
+594
| +1% | +$18.9K | 1.99% | 14 |
|
|
2014
Q4 | $1.8M | Buy |
+60,767
| New | +$1.74M | 1.73% | 24 |
|
Other funds holding PFE
VCM
VPM
Leisure Capital Management's PFE Position: Q1 2026 in Review
Leisure Capital Management held its Pfizer (PFE) position steady in Q1 2026 at 9,483 shares worth $266K. The position accounts for 0.09% of the portfolio, ranked #126.
Leisure Capital Management first reported a position in PFE in Q4 2014 and has held it in 46 quarters since. The position peaked at $2.06M in Q2 2016. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Leisure Capital Management held 9,483 shares of Pfizer worth $266K as of Q1 2026.
- Leisure Capital Management left its Pfizer share count unchanged in Q1 2026.
- Pfizer made up 0.09% of Leisure Capital Management's portfolio in Q1 2026, its #126 holding.
- Leisure Capital Management first reported a position in Pfizer in Q4 2014 and has held it in 46 quarters since.
- Leisure Capital Management's Pfizer position peaked at $2.06M in Q2 2016.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Leisure Capital Management's 13F filing for Q1 2026, filed 8 May 2026.